首页 > 最新文献

Casopis lekaru ceskych最新文献

英文 中文
Operability of lung cancer at the Department of Pulmonology, 2nd Faculty of Medicine, Charles University and Motol University Hospital in Prague in 2024 and its development in the Czech Republic in the last 45 years. 查尔斯大学第二医学院肺科和布拉格Motol大学医院2024年肺癌的可操作性及其在捷克共和国近45年的发展。
Q4 Medicine Pub Date : 2025-01-01
Miloslav Marel, Libor Fila, Dmitry Rakita, Luis Fernando Casas Mendéz, Leona Koubková, Alžběta Bejčková, Zdeňka Chládková, Robert Lischke, Jan Šimonek, Monika Švorcová

In 2024, the multidisciplinary team of the Department of Pulmonology, 2nd Faculty of Medicine, Charles University and Motol University Hospital discussed 454 cases of patients with lung cancer; There were 70 (16%) operated on that year. Patients with adenocarcinoma (52%) in TNM stages I to IIIB prevailed among the operated patients. We administered immunochemotherapy as neoadjuvant treatment to 18 of the operated patients, and 61% of them experienced complete pathological regression. Lobectomies (86%) were significantly more prevalent among surgical procedures, only once the procedure ended with exploratory thoracotomy. We have achieved a 55% agreement between cTNM and pTNM. No one died within 30 days after the operation. We compared the current results of lung cancer surgery with similar groups of patients from outpatient and clinical departments from the last 45 years. During this time, the number of indications for resection treatment did not increase. The proportion of morphological types of lung carcinoma has changed (increase in adenocarcinomas), procedures performed in patients (lobectomies clearly predominate today) and the number of patients operated on in stages IIIA and IIIB has increased slightly. The agreement between the clinically evaluated extent of the tumor and its actual size determined by the pathologist remains at a very good level, as in the past, and is comparable to the results of the most advanced centers in the world. The number of indications for resection depends on the timeliness of diagnosis. At present, less than 20% of patients with lung cancer are diagnosed in TNM stages I and II. We see a possible improvement in the increase in the number of participants in lung cancer screening using low-dose CT, which is well organized and available to all interested parties from 2022. The results of this screening known so far confirm a 57% representation of stages I and II of TNM in patients detected in this way.

2024年,Charles大学第二医学院肺科多学科团队与Motol大学医院共讨论肺癌患者454例;当年手术70例(16%)。手术患者中以TNM I ~ IIIB期腺癌患者居多(52%)。我们对18例手术患者进行免疫化疗作为新辅助治疗,61%的患者病理完全消退。肺叶切除术(86%)在外科手术中更为普遍,只有在手术以探查性开胸术结束时才如此。我们在cTNM和pTNM之间达成了55%的协议。手术后30天内无人死亡。我们比较了最近45年来门诊和临床部门的肺癌手术的结果。在此期间,切除治疗的指征数量没有增加。肺癌形态学类型的比例发生了变化(腺癌增加),患者的手术(目前明显以肺叶切除术为主),IIIA期和IIIB期手术的患者数量略有增加。与过去一样,临床评估的肿瘤范围与病理学家确定的肿瘤实际大小之间的一致性保持在非常好的水平,并且与世界上最先进的中心的结果相当。切除指征的数量取决于诊断的及时性。目前,不到20%的肺癌患者被诊断为TNM I期和II期。我们看到参与肺癌低剂量CT筛查的人数可能会有所增加,该筛查组织良好,并从2022年起向所有感兴趣的各方开放。迄今为止已知的筛查结果证实,以这种方式检测到的患者中,有57%为TNM的I期和II期。
{"title":"Operability of lung cancer at the Department of Pulmonology, 2nd Faculty of Medicine, Charles University and Motol University Hospital in Prague in 2024 and its development in the Czech Republic in the last 45 years.","authors":"Miloslav Marel, Libor Fila, Dmitry Rakita, Luis Fernando Casas Mendéz, Leona Koubková, Alžběta Bejčková, Zdeňka Chládková, Robert Lischke, Jan Šimonek, Monika Švorcová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 2024, the multidisciplinary team of the Department of Pulmonology, 2nd Faculty of Medicine, Charles University and Motol University Hospital discussed 454 cases of patients with lung cancer; There were 70 (16%) operated on that year. Patients with adenocarcinoma (52%) in TNM stages I to IIIB prevailed among the operated patients. We administered immunochemotherapy as neoadjuvant treatment to 18 of the operated patients, and 61% of them experienced complete pathological regression. Lobectomies (86%) were significantly more prevalent among surgical procedures, only once the procedure ended with exploratory thoracotomy. We have achieved a 55% agreement between cTNM and pTNM. No one died within 30 days after the operation. We compared the current results of lung cancer surgery with similar groups of patients from outpatient and clinical departments from the last 45 years. During this time, the number of indications for resection treatment did not increase. The proportion of morphological types of lung carcinoma has changed (increase in adenocarcinomas), procedures performed in patients (lobectomies clearly predominate today) and the number of patients operated on in stages IIIA and IIIB has increased slightly. The agreement between the clinically evaluated extent of the tumor and its actual size determined by the pathologist remains at a very good level, as in the past, and is comparable to the results of the most advanced centers in the world. The number of indications for resection depends on the timeliness of diagnosis. At present, less than 20% of patients with lung cancer are diagnosed in TNM stages I and II. We see a possible improvement in the increase in the number of participants in lung cancer screening using low-dose CT, which is well organized and available to all interested parties from 2022. The results of this screening known so far confirm a 57% representation of stages I and II of TNM in patients detected in this way.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"118-124"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Czech doctors in Ukraine - MEDEVAC mission. 捷克医生在乌克兰的医疗后送任务。
Q4 Medicine Pub Date : 2025-01-01
Miroslav Streck, Filip Burget, Jakub Holoubek

A multidisciplinary medical team from several Czech hospitals participated in a mission to a hospital in the Ukrainian town of Vynnyky as part of the MEDEVAC project. Civilian patients were provided with specialized surgical care in cooperation with plastic surgeons for injuries related to combat operations and without it. A case of a complex open fracture of the forearm bones with extensive defect of soft tissues and skeleton in a 32-year-old civilian patient is briefly described.

作为医疗后送项目的一部分,来自捷克几家医院的一个多学科医疗队参加了前往乌克兰Vynnyky镇一家医院的特派团。与整形外科医生合作,为平民病人提供与战斗行动有关和非战斗行动有关的特殊外科治疗。一个复杂的开放性骨折的前臂骨与广泛的缺损软组织和骨骼在一个32岁的平民病人是简要描述。
{"title":"Czech doctors in Ukraine - MEDEVAC mission.","authors":"Miroslav Streck, Filip Burget, Jakub Holoubek","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A multidisciplinary medical team from several Czech hospitals participated in a mission to a hospital in the Ukrainian town of Vynnyky as part of the MEDEVAC project. Civilian patients were provided with specialized surgical care in cooperation with plastic surgeons for injuries related to combat operations and without it. A case of a complex open fracture of the forearm bones with extensive defect of soft tissues and skeleton in a 32-year-old civilian patient is briefly described.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"87-89"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basic legal prerequisites for secondary use of genomic data for scientific purposes. 为科学目的而二次使用基因组数据的基本法律先决条件。
Q4 Medicine Pub Date : 2025-01-01
Jaroslav Jirsa, Věra Franková

The aim of genomic data sharing is to enable secure access to this data, primarily for research, personalized healthcare and health policy-making. Data sharing has the potential to accelerate research and bring about significant advances in the understanding of health and disease, but it faces legal and ethical issues related to the protection of privacy and confidentiality of information. In addition to the often counterintuitive European legislation leading to different legal interpretations, there are other national rules in individual European Union countries that can further specify the handling of genomic data. This diversity complicates international cooperation and data sharing, not only in genetics but also in other areas of biomedical research. This thesis analyzes the basic legal framework and its application enabling the sharing of genomic data and clarifies the concepts of further processing, secondary use and purpose of data processing. Furthermore, it stresses the importance of data subjects' consent and specific exceptions to the general ban on processing sensitive data. For effective sharing of genomic data, it is essential to comply with European and national legislation, including a clear definition of the purpose and legal basis of processing. International cooperation requires regulatory harmonization and robust data management. This paper analyzes the fundamental dynamics and legality of data sharing in the field of genomic research.

基因组数据共享的目的是确保能够安全地访问这些数据,主要用于研究、个性化保健和卫生决策。数据共享有可能加速研究并在了解健康和疾病方面取得重大进展,但它面临着与保护隐私和信息保密有关的法律和伦理问题。除了经常违反直觉的欧洲立法导致不同的法律解释之外,个别欧盟国家还有其他国家规则,可以进一步规定基因组数据的处理。这种多样性使国际合作和数据共享复杂化,不仅在遗传学方面,而且在生物医学研究的其他领域也是如此。本文分析了基因组数据共享的基本法律框架及其应用,阐明了数据进一步处理、二次利用和数据处理目的的概念。此外,它还强调了数据主体同意的重要性以及对一般禁止处理敏感数据的具体例外情况。为了有效地共享基因组数据,必须遵守欧洲和国家立法,包括对处理目的和法律基础的明确定义。国际合作需要监管协调和强有力的数据管理。本文分析了基因组研究领域数据共享的基本动态和合法性。
{"title":"Basic legal prerequisites for secondary use of genomic data for scientific purposes.","authors":"Jaroslav Jirsa, Věra Franková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The aim of genomic data sharing is to enable secure access to this data, primarily for research, personalized healthcare and health policy-making. Data sharing has the potential to accelerate research and bring about significant advances in the understanding of health and disease, but it faces legal and ethical issues related to the protection of privacy and confidentiality of information. In addition to the often counterintuitive European legislation leading to different legal interpretations, there are other national rules in individual European Union countries that can further specify the handling of genomic data. This diversity complicates international cooperation and data sharing, not only in genetics but also in other areas of biomedical research. This thesis analyzes the basic legal framework and its application enabling the sharing of genomic data and clarifies the concepts of further processing, secondary use and purpose of data processing. Furthermore, it stresses the importance of data subjects' consent and specific exceptions to the general ban on processing sensitive data. For effective sharing of genomic data, it is essential to comply with European and national legislation, including a clear definition of the purpose and legal basis of processing. International cooperation requires regulatory harmonization and robust data management. This paper analyzes the fundamental dynamics and legality of data sharing in the field of genomic research.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 2","pages":"57-62"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery in Hradec Králové - history, academic tradition, and notable personalities. 赫拉代克外科Králové -历史、学术传统和著名人物。
Q4 Medicine Pub Date : 2025-01-01
Jiří Páral
{"title":"Surgery in Hradec Králové - history, academic tradition, and notable personalities.","authors":"Jiří Páral","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"218-222"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
80 years of the Faculty of Medicine in Hradec Králové. 赫拉德克医学院成立80年Králové。
Q4 Medicine Pub Date : 2025-01-01
Jiří Manďák
{"title":"80 years of the Faculty of Medicine in Hradec Králové.","authors":"Jiří Manďák","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"187-190"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communication health literacy of war refugees from Ukraine in the Czech Republic. 乌克兰战争难民在捷克共和国的通讯健康素养。
Q4 Medicine Pub Date : 2025-01-01
Karolína Dobiášová

Communicative health literacy is essential for effective interaction between patients and healthcare professionals. Its limitations may contribute to health inequalities. Ukrainian war refugees face significant barriers in accessing healthcare, primarily due to language and cultural differences. This study analyses their level of communicative health literacy and compares it with the Czech population. A quantitative study was conducted using the standardized HLS19-COM-P questionnaire. In November 2023, 1,182 Ukrainian refugees were surveyed using the CAWI method. Data analysis was performed using IBM SPSS Statistics software version 28. The communicative health literacy of refugees was significantly lower than that of the Czech population. The most significant barriers included difficulties in expressing health problems (40%), asking questions to physicians (50%), and participating in shared decision-making (55%). A low level of communicative health literacy was associated with poorer utilization of healthcare services. To reduce health inequalities, it is necessary to strengthen language support for refugees, increase the availability of intercultural mediators, and implement educational programs aimed at improving communicative health literacy.

沟通健康素养对于患者和医疗保健专业人员之间的有效互动至关重要。它的局限性可能导致保健不平等。乌克兰战争难民在获得医疗保健方面面临重大障碍,主要是由于语言和文化差异。本研究分析了他们的沟通健康素养水平,并将其与捷克人口进行了比较。采用标准化的HLS19-COM-P问卷进行定量研究。2023年11月,使用CAWI方法对1182名乌克兰难民进行了调查。采用IBM SPSS统计软件28版进行数据分析。难民的沟通健康素养明显低于捷克人口。最严重的障碍包括难以表达健康问题(40%)、向医生提问(50%)和参与共同决策(55%)。沟通卫生素养水平低与卫生保健服务利用率较低有关。为了减少卫生不平等,有必要加强对难民的语言支持,增加跨文化调解人的可用性,并实施旨在提高沟通卫生素养的教育方案。
{"title":"Communication health literacy of war refugees from Ukraine in the Czech Republic.","authors":"Karolína Dobiášová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Communicative health literacy is essential for effective interaction between patients and healthcare professionals. Its limitations may contribute to health inequalities. Ukrainian war refugees face significant barriers in accessing healthcare, primarily due to language and cultural differences. This study analyses their level of communicative health literacy and compares it with the Czech population. A quantitative study was conducted using the standardized HLS19-COM-P questionnaire. In November 2023, 1,182 Ukrainian refugees were surveyed using the CAWI method. Data analysis was performed using IBM SPSS Statistics software version 28. The communicative health literacy of refugees was significantly lower than that of the Czech population. The most significant barriers included difficulties in expressing health problems (40%), asking questions to physicians (50%), and participating in shared decision-making (55%). A low level of communicative health literacy was associated with poorer utilization of healthcare services. To reduce health inequalities, it is necessary to strengthen language support for refugees, increase the availability of intercultural mediators, and implement educational programs aimed at improving communicative health literacy.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 1","pages":"17-24"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the diagnosis and treatment of male infertility - an overview of current methods. 男性不育症的诊断与治疗进展——当前方法综述。
Q4 Medicine Pub Date : 2025-01-01
Marek Broul, Aneta Hujová, Michaela Liegertová

Male infertility is a multifactorial condition influenced by hormonal, anatomical, genetic, and lifestyle factors. Although the male factor contributes to up to 40% of infertility cases, the exact etiology often remains unknown (so-called idiopathic infertility). Current diagnostic approaches include detailed clinical evaluation, semen analysis, hormonal assessment, genetic testing, and imaging techniques. Significant progress has been achieved in sperm DNA fragmentation testing and oxidative stress evaluation, offering a broader insight into sperm quality. Treatment strategies vary depending on the underlying cause, ranging from pharmacological therapy and surgical interventions to assisted reproductive technologies. Rapid advances in regenerative medicine and gene therapy show promise for novel therapeutic options. A healthy lifestyle and risk factor management are integral to both prevention and treatment.

男性不育症是一种多因素的疾病,受激素、解剖学、遗传和生活方式等因素的影响。尽管男性因素导致高达40%的不孕症病例,但确切的病因通常仍不清楚(所谓的特发性不孕症)。目前的诊断方法包括详细的临床评估、精液分析、激素评估、基因检测和成像技术。精子DNA断裂检测和氧化应激评价取得了重大进展,为精子质量的研究提供了更广阔的视角。治疗策略因病因而异,从药物治疗和手术干预到辅助生殖技术。再生医学和基因疗法的快速发展为新的治疗选择提供了希望。健康的生活方式和风险因素管理是预防和治疗的组成部分。
{"title":"Advances in the diagnosis and treatment of male infertility - an overview of current methods.","authors":"Marek Broul, Aneta Hujová, Michaela Liegertová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Male infertility is a multifactorial condition influenced by hormonal, anatomical, genetic, and lifestyle factors. Although the male factor contributes to up to 40% of infertility cases, the exact etiology often remains unknown (so-called idiopathic infertility). Current diagnostic approaches include detailed clinical evaluation, semen analysis, hormonal assessment, genetic testing, and imaging techniques. Significant progress has been achieved in sperm DNA fragmentation testing and oxidative stress evaluation, offering a broader insight into sperm quality. Treatment strategies vary depending on the underlying cause, ranging from pharmacological therapy and surgical interventions to assisted reproductive technologies. Rapid advances in regenerative medicine and gene therapy show promise for novel therapeutic options. A healthy lifestyle and risk factor management are integral to both prevention and treatment.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 2","pages":"43-49"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of the regulation of surrogacy from the point of view of civil, medical and criminal law. 从民法、医学和刑法的角度对代孕进行监管的重要性。
Q4 Medicine Pub Date : 2025-01-01
Lenka Teska Arnoštová, Jana Tlapák Navrátilová, Ingrid Galovcová

Surrogate motherhood is one of the possible procedures to become a parent, However, it is not legally regulated. Practice shows that there are several problematic or controversial aspects that should be regulated in the interest of all participants, but especially the well-being of the child. The legislation should mainly concern the altruistic principle, the medical indications of the intended and surrogate mother, their medical examinations and approval by the court.

代孕母亲是成为父母的一种可能的程序,但是,它没有法律规定。实践表明,有几个有问题或有争议的方面应该为了所有参与者的利益,特别是为了儿童的福祉而加以管制。立法应主要涉及利他原则、准母亲和代孕母亲的医学指征、她们的医学检查和法院的批准。
{"title":"The importance of the regulation of surrogacy from the point of view of civil, medical and criminal law.","authors":"Lenka Teska Arnoštová, Jana Tlapák Navrátilová, Ingrid Galovcová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Surrogate motherhood is one of the possible procedures to become a parent, However, it is not legally regulated. Practice shows that there are several problematic or controversial aspects that should be regulated in the interest of all participants, but especially the well-being of the child. The legislation should mainly concern the altruistic principle, the medical indications of the intended and surrogate mother, their medical examinations and approval by the court.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 2","pages":"50-56"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amiodarone-induced thyreopaties. Amiodarone-induced thyreopaties。
Q4 Medicine Pub Date : 2025-01-01
Adela Krausová

Amiodarone-induced thyroid dysfunction represents a serious complication of treatment with amiodarone, a frequently used potent antiarrhythmic drug. In clinical practice, there are two main forms: hypothyroidism and hyperthyroidism. Amiodarone-induced thyrotoxicosis is further divided into type 1 and type 2 with different pathogenesis, diagnostic findings and, most importantly for the patient, therapeutic approach. Due to frequent diagnostic overlap, a mixed form of amiodarone-induced thyrotoxicosis is also recognized, requiring a combination of both distinct treatment strategies, antithyroid drugs and glucocorticoids. Amiodarone-induced type 1 thyrotoxicosis necessitates prospective discontinuation of amiodarone therapy; in type 2 this step is usually not warranted. In hypothyroidism, substitution therapy with levothyroxine is sufficient without the need to stop antiarrhythmic treatment with amiodarone. Amiodarone-induced thyrotoxicosis may significantly increase the incidence of cardiovascular complications. If amiodarone treatment is discontinued solely for cardiological indications, patients without a history of thyroid disease usually experience restoration of normal thyroid function. However, in predisposed individuals, dysfunction may persist or recur following repeated iodine exposure.

胺碘酮是一种常用的强效抗心律失常药物,其诱导的甲状腺功能障碍是治疗的严重并发症。在临床实践中,主要有两种形式:甲状腺功能减退症和甲状腺功能亢进症。胺碘酮引起的甲状腺毒症又分为1型和2型,它们具有不同的发病机制、诊断结果以及对患者最重要的治疗方法。由于频繁的诊断重叠,混合形式的胺碘酮引起的甲状腺毒症也被确认,需要两种不同的治疗策略,抗甲状腺药物和糖皮质激素的组合。胺碘酮诱导的1型甲状腺毒症需要前瞻性停止胺碘酮治疗;在类型2中,这一步通常是不必要的。在甲状腺功能减退症中,用左甲状腺素替代治疗就足够了,不需要停止胺碘酮抗心律失常治疗。胺碘酮引起的甲状腺毒症可能显著增加心血管并发症的发生率。如果胺碘酮治疗仅因心脏病指征而停止,无甲状腺疾病史的患者通常会恢复正常的甲状腺功能。然而,在易感个体中,功能障碍可能在反复碘暴露后持续存在或复发。
{"title":"Amiodarone-induced thyreopaties.","authors":"Adela Krausová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Amiodarone-induced thyroid dysfunction represents a serious complication of treatment with amiodarone, a frequently used potent antiarrhythmic drug. In clinical practice, there are two main forms: hypothyroidism and hyperthyroidism. Amiodarone-induced thyrotoxicosis is further divided into type 1 and type 2 with different pathogenesis, diagnostic findings and, most importantly for the patient, therapeutic approach. Due to frequent diagnostic overlap, a mixed form of amiodarone-induced thyrotoxicosis is also recognized, requiring a combination of both distinct treatment strategies, antithyroid drugs and glucocorticoids. Amiodarone-induced type 1 thyrotoxicosis necessitates prospective discontinuation of amiodarone therapy; in type 2 this step is usually not warranted. In hypothyroidism, substitution therapy with levothyroxine is sufficient without the need to stop antiarrhythmic treatment with amiodarone. Amiodarone-induced thyrotoxicosis may significantly increase the incidence of cardiovascular complications. If amiodarone treatment is discontinued solely for cardiological indications, patients without a history of thyroid disease usually experience restoration of normal thyroid function. However, in predisposed individuals, dysfunction may persist or recur following repeated iodine exposure.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"94-99"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Little-known first autopsies in the Czech lands. 捷克境内鲜为人知的首次尸检。
Q4 Medicine Pub Date : 2025-01-01
David Krá

The autopsy performed by Ján Jesenský in 1600 is often perceived as the first autopsy in the history of Czech medicine. However, when examining historical sources and previously published articles, it turns out that several autopsies had been performed in our territory earlier. The article presents these events chronologically and with available details.

1600年由Ján Jesenský进行的尸检通常被认为是捷克医学史上的第一次尸检。然而,在查阅历史资料和以前发表的文章时,发现早些时候曾在我国境内进行过几次尸体解剖。本文按时间顺序介绍了这些事件,并提供了可用的详细信息。
{"title":"Little-known first autopsies in the Czech lands.","authors":"David Krá","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The autopsy performed by Ján Jesenský in 1600 is often perceived as the first autopsy in the history of Czech medicine. However, when examining historical sources and previously published articles, it turns out that several autopsies had been performed in our territory earlier. The article presents these events chronologically and with available details.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 6","pages":"270-272"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Casopis lekaru ceskych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1